Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Mithra Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 607.54M |
| November 21, 2024 | 607.54M |
| November 20, 2024 | 607.54M |
| November 19, 2024 | 607.54M |
| November 18, 2024 | 607.54M |
| November 15, 2024 | 607.54M |
| November 14, 2024 | 607.54M |
| November 13, 2024 | 607.54M |
| November 12, 2024 | 607.54M |
| November 11, 2024 | 607.54M |
| November 08, 2024 | 607.54M |
| November 07, 2024 | 607.54M |
| November 06, 2024 | 607.54M |
| November 05, 2024 | 607.54M |
| November 04, 2024 | 607.54M |
| November 01, 2024 | 607.54M |
| October 31, 2024 | 607.54M |
| October 30, 2024 | 607.54M |
| October 29, 2024 | 607.54M |
| October 28, 2024 | 607.54M |
| October 25, 2024 | 607.54M |
| October 24, 2024 | 607.54M |
| October 23, 2024 | 607.54M |
| October 22, 2024 | 607.54M |
| October 21, 2024 | 607.54M |
| Date | Value |
|---|---|
| October 18, 2024 | 607.54M |
| October 17, 2024 | 607.54M |
| October 16, 2024 | 607.54M |
| October 15, 2024 | 607.54M |
| October 14, 2024 | 607.54M |
| October 11, 2024 | 607.54M |
| October 10, 2024 | 607.54M |
| October 09, 2024 | 607.54M |
| October 08, 2024 | 607.54M |
| October 07, 2024 | 607.54M |
| October 04, 2024 | 607.54M |
| October 03, 2024 | 607.54M |
| October 02, 2024 | 607.54M |
| October 01, 2024 | 607.54M |
| September 30, 2024 | 607.54M |
| September 27, 2024 | 607.54M |
| September 26, 2024 | 607.54M |
| September 25, 2024 | 607.54M |
| September 24, 2024 | 607.54M |
| September 23, 2024 | 607.54M |
| September 20, 2024 | 607.54M |
| September 19, 2024 | 607.54M |
| September 18, 2024 | 607.54M |
| September 17, 2024 | 607.54M |
| September 16, 2024 | 607.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
507.88M
Minimum
Sep 07 2022
1.157B
Maximum
Feb 01 2022
652.12M
Average
607.54M
Median
Sep 18 2023
Enterprise Value Benchmarks
| Galapagos NV | -1.941B |
| UCB SA | 37.88B |
| Nyxoah SA | 241.66M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 95.14M |